4//SEC Filing
Anika Therapeutics, Inc. 4
Accession 0001171843-16-013102
$ANIKCIK 0000898437operating
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 7:05 PM ET
Size
12.0 KB
Accession
0001171843-16-013102
Insider Transaction Report
Form 4
BOWER JOSEPH I
Director
Transactions
- Exercise/Conversion
Stock Appreciation Right
2016-11-07−1,540→ 0 totalExercise: $12.36→ Common Stock (1,540 underlying) - Tax Payment
Common Stock
2016-11-07$44.26/sh−431$19,076→ 38,082 total - Sale
Common Stock
2016-11-09$43.31/sh−40$1,732→ 37,542 total - Exercise/Conversion
Common Stock
2016-11-07$12.36/sh+1,540$19,034→ 38,513 total - Sale
Common Stock
2016-11-09$43.40/sh−500$21,700→ 37,582 total
Footnotes (3)
- [F1]Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016.
- [F2]Reflects 431 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 7, 2016.
- [F3]Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000898437
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 7:05 PM ET
- Size
- 12.0 KB